H.C. Wainwright Raises Price Target on Immunovant (IMVT) Following Positive Rheumatoid Arthritis Trial Data
Immunovant, Inc. (NASDAQ:IMVT) ranks among the best short squeeze stocks to invest in. On May 21, H.C. Wainwright boosted Immunovant, Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 9,341,151 | $359,914,548 | -19% | 5.24% |
| 2. | Farallon Capital Thomas Steyer | 5,805,000 | $223,666,650 | +276% | 1.03% |
| 3. | Baker Bros. Advisors Julian Baker And Felix Baker | 5,435,220 | $209,419,027 | -1% | 1.05% |
| 4. | Two Seas Capital Sina Toussi | 3,148,505 | $121,311,898 | -2% | 2.4% |
| 5. | ADAR1 Capital Management Daniel Schneeberger | 2,330,716 | $89,802,487 | -14% | 4.11% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.00 | 16,666,666 | $349,999,986.00 | 113,317,007 | 2025-12-12 | Filing | |
| $20.00 | 16,845,010 | $336,900,200.00 | 96,650,341 | 2025-01-13 | Filing | |
| $38.00 | 1,526,316 | $58,000,008.00 | 79,805,331 | 2023-10-02 | Filing | |
| $6.00 | 416,667 | $2,500,002.00 | 73,805,331 | 2022-10-06 | Filing | |
| $5.60 | 15,000 | $84,000.00 | 20,000 | 2022-09-30 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $44.16 | 3,056 | $134,952.96 | 219,301 | 2026-08-20 | Filing | |
| $39.80 | 1,500 | $59,700.00 | 116,731 | 2026-07-24 | Filing | |
| $38.69 | 6,798 | $263,014.62 | 240,798 | 2026-07-23 | Filing | |
| $38.69 | 2,857 | $110,537.33 | 205,341 | 2026-07-23 | Filing | |
| $39.99 | 106 | $4,238.94 | 222,357 | 2026-07-08 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,186,469 | $623,664,634 | 0.03% | |
| 2. | 7,180,897 | $276,679,973 | 0% | |
| 3. | 4,617,005 | $177,893,203 | 0.01% | |
| 4. | 4,534,833 | $174,727,164 | 0.01% | |
| 5. | 4,457,988 | $171,766,278 | 4.13% |